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Investigation of the results of a smoking cessation clinic and the
factors associated with success
Leyla SAĞLAM

Aim: To investigate the success rate and factors affecting success at a smoking cessation clinic.
Materials and methods: In this study, 608 patients (397 male and 211 female) admitted to a smoking cessation clinic to
quit smoking between 1 January 2006 and 1 June 2010 were investigated. Routine biochemical and hematological tests,
pulmonary function tests, exhaled carbon monoxide levels, electrocardiographs, and chest X-rays were obtained from
all of the patients. The questionnaire forms, including the Fagerström Test for Nicotine Dependence (FTND), were filled
by all of the participants. At the end of months 6, 12, and 18, the smoking cessation success rates were reviewed. Factors
contributing to the success rate, causes of smoking, difficulties encountered in quitting, and factors that increased the
desire to smoke were evaluated. SPSS 11 was used in the statistical analyses (chi-square test). P < 0.05 was considered
statistically significant.
Results: Statistically significant factors included male sex, obtaining physician advice, and an FTND score of ≤6.
Inclination was the most common cause of starting to smoke, and the most commonly encountered difficulty in quitting
was irritability and an increased desire to smoke in the postprandial period.
Conclusion: This study found a smoking cessation success rate of 40.4% over 1 year. The clinic was effective for smoking
cessation. The findings from this clinic will be valuable for future tobacco control studies.
Key words: Tobacco control, smoking cessation clinic, smoking addiction

Sigara bırakma kliniği sonuçları ve başarıyı etkileyen faktörlerin araştırılması
Amaç: Bu çalışmada, sigara bırakma (SB) polikliniğimizde başarı oranını ve başarıyı artıran faktörleri araştırmayı
amaçladık.
Yöntem ve gereç: Çalışmamızda, 1 Ocak 2006 ve 1 Temmuz 2010 tarihleri arasında SB polikliniğimize başvuran 608
(397 erkek, 211 kadın) olgu incelendi. Olgulardan rutin biokimyasal, hematolojik testler, solunum fonksiyon testi,
nefes CO ölçümü, elektrokardiografi ve postero-anterior akciğer grafisi istendi. Tüm olgulardan, sigara içme durumu,
Fagerström nikotin bağımlılık testi (FTND) ve demografik bilgilerin yer aldığı poliklinik formunu doldurmaları istendi.
Altı, 12 ve 18. ayın sonunda sigara bırakma oranları gözden geçirildi. Başarıyı etkileyen faktörler, sigaraya başlama
nedenleri, bırakırken karşılaşılan güçlükler ve sigara içme isteğini artıran faktörler değerlendirildi. İstatistik analizde
SPSS 11 (ki-kare testi) programı kullanıldı. P < 0,05 anlamlı kabul edildi.
Bulgular: İstatistiksel olarak başarıyı etkiliyen faktörler, erkek cinsiyet, sigara bırakmaları için doktor tavsiyesi alma
ve düşük (6 ≤ FTND) bağımlılık olarak saptandı. Sigaraya başlamada en sık neden özenme, sigarayı bırakırken en sık
karşılaşılan güçlük sinirlilik ve sigara içme isteğinin en yüksek olarak yemek sonrasında olduğu saptandı.
Sonuç: Bu çalışmada başarı oranı bir yıl için % 40,4 olarak bulundu. Sigara bırakma polikliniği, başarılı sigara bırakmada
etkin ve önemliydi. Elde edilen bilgilerin tütün konrolü için gelecekte yapılacak çalışmalar için yararlı olacağını
düşünmekteyiz.
Anahtar sözcükler: Tütün kontrolü, sigara bırakma kliniği, sigara bağımlılığı
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Introduction
Smoking cessation (SC) clinics are important medical
establishments for tobacco control. These clinics have
been established to assist smokers with SC.
Tobacco use is globally associated with mortality
and morbidity due to chronic obstructive pulmonary
disease (COPD), lung cancer, and other pulmonary
diseases. Tobacco addiction is a disease that produces
neurochemical and behavioral changes. Brief
intervention approaches are the first step in SC and
have an important role. Encouraging smokers who
wish to quit will help ease the process of quitting.
In SC, combination therapy, or behavioral therapy
with pharmacotherapy, is better than a single therapy
method and significantly increases the success rate of
abstinence. Additionally, Internet SC programs are
useful. For example, quitlines have provided effective
results for many people. SC programs should be
supported by the media, as media messages have an
important role in the success of these programs.
Tobacco use is a major contributor to the burden
of health expenses. The disease burden related to
tobacco use is declining in developed countries but
has continued to increase in developing countries.
National interventions for SC may provide
an important public health benefit, especially
in developing countries. SC clinics that provide
professional support are useful establishments. Public
education, economic precautions, national laws and
regulations, and evidence-based policy interventions
are effective and should be used extensively. Tobacco
control strategies have contributed to dramatic
declines in the prevalence of smoking.

Test for Nicotine Dependence (FTND) (1), and
questions about the patient’s smoking habits were
completed by all of the participants. The age of the
patients ranged from 14 to 74 years.
At the end of months 6, 12, and 18, the SC success
rates were reviewed. The patients were divided into
groups based on many factors, such as sex, age at
which they began smoking, and their FTND score
(a score of 6 or lower versus a score of 7 or higher).
PFTs, treatment options, educational level, amount of
nicotine use, and job status were investigated for their
effects on the success rate. The reason for starting
to smoke, the difficulties encountered while trying
to quit, and the factors that increased the desire to
smoke were evaluated.
SPSS 11 was used in the statistical analyses. Chisquare tests were applied to evaluate the data. P <
0.05 was considered statistically significant.
Results
In this study, 608 patients (65%, n = 397 male; 35%,
n = 211 female) were included. The mean ages were
40 ± 12 years for male participants and 37 ± 10 years
for female participants (an overall range of 14-74,
overall mean age of 39 ± 11). Previous thoughts of
quitting smoking were reported by 85% (n = 518) of
the patients, and 81% (n = 499) had attempted to quit
smoking.
Inclination was the most common reason why
participants started smoking (Figure 1). Irritability
and the desire to smoke were the most commonly
reported complaints while quitting (Figure 2). Meals
were the most common trigger of cravings to smoke
(Figure 3).

Materials and methods
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Reasons for starting to smoke (percentage)
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Figure 1. Reasons for starting to smoke.
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In this study, 608 patients (397 male and 211 female)
admitted to the smoking cessation clinic of the
Department of Chest Disease of Atatürk University,
Erzurum, Turkey, between 1 January 2006 and 1
June 2010 were investigated. Routine biochemical
and hematological tests, pulmonary function tests
(PFTs), expiratory carbon monoxide (CO) levels,
electrocardiographs, and chest X-rays were obtained
from all of the patients, and the results of these tests
were recorded in their files. A standardized form that
included demographic information, the Fagerström
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Difficulties encountered while quitting (percentage)
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Figure 2. Difficulties encountered while quitting.

Figure 3. Factors increasing the desire to smoke.

The SC success rate was higher in males than in
females, especially at the end of month 18 (P = 0.001)
(Table 1).

COPD, early-stage lung cancer, and cardiovascular
disease were diagnosed in 7, 2, and 5 patients,
respectively.

It was demonstrated that a physician’s advice to
quit smoking was an important factor. At the end of
months 6 and 12, the SC success rate was statistically
significant (P = 0.002 and P = 0.001, respectively)
(Table 2).
The SC success rate was higher in the group with
an FTND score of ≤6 than in the other group. This
result was statistically significant, especially at month
6 (Table 2).
The participant’s job status, age at which he or
she began smoking, educational level, cigarette
consumption (in packs/day and packs/year), forced
expiratory volume per second (FEV1), and forced
vital capacity (FVC) did not impact the success of SC
(Table 2).
Most patients (82%) were given behavioral +
nicotine replacement therapy (NRT) treatment. All
of the treatment methods had similar results (Table
2).
Male sex, advice from a physician, and an FTND
score of ≥6 were statistically significant factors.

Discussion
SC clinics are important for tobacco control
worldwide. These clinics have been established to
assist to smokers in quitting. In Turkey, the number
of these clinics has increased over time.
The success rate of SC in 1 year varies from clinic
to clinic, from 10% to 43.2% (Table 3) (1-12). The
causes of these differences may include population
differences, the numbers of patients, or treatment
methods. In the present study, the success rate was
higher than that of other studies at month 6, but the
results were similar to those of other studies at month
12. There are no studies with which to compare the
results after 18 months. It is known that the success
rate of quitting varies in the early and late periods.
Generally, success rates are higher in the early period
than in the late period. To increase the long-term
success rate, intensive support must be provided to
smokers while they are quitting and be continued
afterwards.

Table 1. Smoking cessation success rates at 6, 12, and 18 months according to sex.
Sex / Months

6 months (%)

12 months (%)

18 months (%)

Female

49

38

24

Male

53

48

34

P-value

0.4

0.4

0.01
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Table 2. Success rates at 6, 12, and 18 months according to the reason for clinic admission, employment status, age when smoking was
initiated, FTND scores, FEV1/FVC (%), educational attainment, therapeutic approaches, daily consumption, and packs/year.

Reason for admission

6 months (%)

12 months (%)

18 months (%)

Physician advice (9%)

73

63

44

Patient request (87%)

49

37

30

Other cause (4%)

64

50

36

0.002

0.001

0.08

Employed (56%)

49

41

30

Unemployed (33%)

53

39

32

Retired (11%)

53

45

29

P-value

0.7

0.6

0.8

Before 20 years old (78%)

52

41

32

After 20 years old (22%)

52

38

26

P-value

0.9

0.5

0.2

≤6 (53%)

58

44

35

≥7 (47%)

45

36

27

0.03

0.04

0.03

<70 (13%)

50

42

32

≤70 (87%)

52

41

31

P-value

0.7

0.8

0.9

Primary school graduate (20%)

55

45

35

Middle school graduate (12%)

53

45

33

High school graduate (32%)

52

40

32

University graduate (34%)

49

38

28

P-value

0.7

0.5

0.5

54

38

35

B + NRT (82%)

50

40

30

B + NRT+ bupropion (2%)

67

33

33

B + bupropion (7%)

69

53

38

B + varenicline (3%)

65

55

30

P-value

0.7

0.2

0.8

≤1 pack per day (65%)

55

44

34

>1 pack per day (35%)

46

32

27

0.05

0.08

0.08

≤20 packs/year (83%)

52

41

32

>20 packs/year (17%)

50

39

28

P-value

0.5

0.7

0.5

P-value
Employment status

Age when smoking was initiated

FTND scores

P-value
FEV1/FVC (%)

Educational attainment

Therapeutic approaches

Behavioral (6%)
1

Daily consumption

2

P-value
Packs/year

1

B, behavioral; 2NRT, nicotine replacement treatments.
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Table 3. Comparison of the success rates (%) in previous studies with the present study.

Studies

Success rate (%) at the end of each period (months)
3

6

ACS and AASCc1 (2)
Foulds et al. (3)

9

21.42
17.7

43.26

Tonnesen et al. (4)

24

TNSG2 (4)

26
36
32

Zow et al. outpatient group inpatient group (5)
27

Fung et al. (7)

32

Demir et al. (8)

33.6

Sippel et al. (9)
Smith et al. (10)

18

17.87

Akkaya et al. (4)

Giraud et al. (6)

12

11
*29.9

Rovina et al. (11)

**34.3

Pardell et al. (12)

42.7

33.7

Present study

51.7

40.4

30.9

*Bupropion + lozenge.
**Bupropion SR + cognitive behavioral group therapy.
1
American Cancer Society and American Lung Association Smoking Cessation clinics.
2
Transdermal Nicotine Study Group.

Most smokers have considered quitting and have
attempted to quit smoking. In this study, this rate
was 81%. In a study by Lando et al., the rate of quit
attempts was 82.9% (2). The rate of prior quit attempts
was 79%-85% in another study (9). In the study by
Lando et al., most current smokers (71.8%) indicated
that they had previously tried to quit (13). Similarly,
70% of Americans who smoke say that they would
like to quit. Approximately 30% of those Americans
make a serious quit attempt each year. Fewer than
10% of these succeed in quitting permanently (14).
Generally, the results of all of the studies regarding
quit attempts have been similar.
Physician advice is one of the most effective
factors to encourage SC. In this study, physician
advice was a significant factor for the success rate (P =
0.001). This factor also had an important role in other
studies. Therefore, healthcare professionals should be
encouraged to advise and motivate patients to quit

smoking. All physicians should ask all patients if they
smoke and whether they are willing to quit. Among
the participants in this study who received physician
advice to quit smoking, the cessation rate was
significantly greater than among those who did not
receive this advice (15). In a study in Switzerland by
Eckert and Junker, physician advice to quit smoking
motivated patients and increased their desire to
quit (53%), especially among heavier smokers (16).
Ossip-Klein et al., in their investigation, found that
over half of smokers over 50 years of age had received
physician advice to quit and that the advice had
influenced the patient’s decision “extremely” or “quite
a lot.” Approximately one-third of patients indicated
that this advice increased their confidence in quitting
(17). Gilpin et al. compared smokers who had never
been advised to quit by their physician and those who
had been advised to quit at their last visit. Quitting
attempts were higher in smokers who were advised
519
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to quit by their physicians (18). Almost half (46.5%)
of the current smokers indicated that a physician had
advised them to quit smoking. Furthermore, 56.6%
indicated that advice from a physician would be
helpful to them in quitting (13).
A physician’s advice to quit smoking is a simple
intervention to incorporate at every visit for every
smoker and has an important impact on tobacco
control. Most smokers visit their family physician
almost every year. Their physician’s advice to quit
will increase their motivation to quit smoking. The
rate of patients referred by a physician was low
(13.6% overall; 5.8% general practitioners, 3.8%
office specialists, and 4% hospital physicians (9).
All physicians must be encouraged to advise their
patients to quit smoking. Physicians are health role
models and leaders, and they can affect attitudes in
the community. It is also important for patients to
quit smoking so that they may serve as a role model
for their children.
Smoking status should be considered as a vital
sign and can be gathered using 2 questions. These
questions should address the patient’s smoking status
and plans to quit, which may encourage an increased
amount of SC counseling by physicians (19). Keeping
records of the smoking status of all patients may also
be important for future practices. If the patient is a
smoker, the physician may intervene earlier to assist
in quitting. Technology-driven interventions have
recently gained popularity, and using these may help
SC programs.
A study by Lindsay et al. found that physicians
who had previously taken part in formal training
programs for SC counseling felt more prepared to
counsel patients and spent more time doing so than
their counterparts who had not received formal
training. These findings suggest that special training
programs for physicians will enhance their perceived
preparedness and increase the likelihood that they will
engage in appropriate strategies with patients (20).
Liu and Tang stated in their letter that physicians
have an ethical obligation to educate their patients
about SC and should routinely provide advice on
quitting (21).
A study demonstrated that a “pay-for-performance
program” substantially increased the rate of clinician
520

referrals to tobacco quitline services (22). Tobacco
quitlines use evidence-based treatments to help
smokers, and smokers can be referred by their
clinicians to these services (20). The “It’s time” SC
program explained that a reduction in the prevalence
of smoking depends on the widespread delivery of
the program to all patients who smoke (23).
In the present study, 13% of the patients had an
FEV1/FVC lower than 70%. This finding was not
significant when compared to the FEV1/FVC values
found in the literature. If the numbers of both groups
were equal or approximately equal, the results may
have been different. It has been shown that a history of
COPD has no effect on the success of SC. The success
rate was 29% in patients with COPD and 49% in the
healthy control group (24). In another study by the
same author, in 2 groups of patients, with pulmonary
disease (such as COPD or lung cancer) and healthy
controls, the smoking quit rate was 41.2% and 38.2%
at the end of 1 year, respectively (P > 0.005). In this
trial, having a serious smoking-related disease did
not motivate smokers to quit smoking (25).
A brief intervention including the 5 As (ask,
assess, advise, assist, and arrange) has increased SC
rates and decreased morbidity and mortality due to
smoking.
Different treatment methods have resulted in
different success rates, but any treatment is better
than a placebo (2,3,8,12). In the present study, a
placebo was not used. We most commonly used NRT
and behavioral support. For other treatments, the
success rate was not statistically significant.
In a study of 300 physicians and pharmacists,
Pardell et al. observed that the success rates of
NRT after 6 and 12 months were 42.7% and 33.7%,
respectively (12). In a study by Demir et al., smokers
were divided into 2 groups. Either NRT, education,
and motivation or only education and motivation
were given to the first and second groups, respectively,
for SC, and the success rates were 33.6% and 10.9%,
respectively (8). Quit rates were 11% at a 9-month
follow-up in another study, in which all of the patients
were given NRT. Most of the patients who wanted to
quit smoking had not used NRT because of the cost.
In the same study, the authors stated that routine
spirometry and CO monitoring might be helpful for
more motivated smokers (9).

L. SAĞLAM

In primary care clinics, the effectiveness of
5 SC pharmacotherapies was investigated. Sixmonth abstinence rates were found to be 16.8% for
bupropion SR, 19.9% for the lozenge, 17.7% for the
patch, 26.9% for the patch + lozenge, and 29.9%
for bupropion + lozenge (10). In another study, if
pharmacotherapy (bupropion SR) was combined
with brief counseling, nonspecific psychological
group support, and cognitive behavioral group
therapy, the chance for success was increased, and
sustained abstinence rates were 29.6%, 28.1%, and
34.3%, respectively, at the end of 12 months (11).
The quit rates were not statistically significant
among the different treatments (36% for bupropion,
36% for nicotine patch, 23% for nicotine patch +
bupropion, and 38% for no pharmacotherapy) (5).
In these studies, different treatment methods were
used, and the results varied. However, combining
the interventions has shown promising results when
compared with a single intervention.
A study suggested that the “use of mass media
is an effective method for informing smokers about
cessation services and that enrolment could be
improved by modifying public messages to address
barriers as well as expanding outreach to specific
demographic groups” (26).
Inclination to quit (“I just decided to quit”)
was more important than NRT or the advice of a
physician for former smokers. In the same literature,
legislated measures (restriction on smoking in public
places and on sales, less advertising, and higher
taxes), cessation aids (cessation clinics, self-help
books, and programs on TV/radio), and information
about the harmful effects of tobacco were helpful
for smokers who wanted to quit (27). Smokers who
were confident in their ability to quit had a higher
abstinence rate (34%) than those who were not (5%)
at 12 months (7).
Male sex, physician’s advice, and an FTND score
of 6 or higher were statistically significant factors in
the present study. Fung et al. demonstrated that the
following factors have been consistently related to
successful abstinence: male sex, lower dependence
on nicotine, older age, higher socioeconomic status

or educational achievement, previous quit attempts,
and health concerns or problems. In the same study,
the prognostic factors favoring SC were as follows:
having no heavy smokers in the family or the nearby
environment, consumption of fewer than 25 cigarettes
with a nicotine content of less than 0.6 mg, smoking
at breakfast or later, an FTND score of less than 6,
and previous attempts to stop smoking lasting more
than 1 week (9). Generally, a lower dependency and
being male were common factors in SC achievement.
In the present study, it was found that patients
frequently experienced irritability (63%) and a
desire to smoke (57.6%) (Figure 2). These rates were
higher during treatment than at other times. Can et
al. found that 52.6% of their patients had complaints
while quitting (28). Stress (56%), irritability (28%),
withdrawal (22%), and weight gain (9%) were factors
that impacted the decision to start smoking again
(7). Irritability (8.5%) and concentration difficulties
(7.4%) were found in another study (8). A resolution
of these problems is important for continuing the
treatment and success in SC.
In the present study, 79% of the subjects had
started smoking before the age of 20. In another
study, 90% of the subjects had started smoking before
the age of 20 (6). There was no statistically significant
difference in the abstinence rates according to the age
at which patients began to smoke.
In conclusion, our clinics were more successful
than most of those in previous studies. A physician’s
advice to quit smoking was the most important
factor related to successful SC. Physicians must be
encouraged to advise all smokers to quit. Additionally,
the level of nicotine dependence was an important
factor for success. Overall, we conclude that SC
clinics improve public health and that the number of
these clinics should be increased.
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